LEADER 01257nam  2200373Ia 450 
001 9910696966603321
005 20230902161849.0
035   $a(CKB)5470000002383224
035   $a(OCoLC)539056494
035   $a(EXLCZ)995470000002383224
100   $a20100304d2006      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $enonclinical safety evaluation of drug or biologic combinations
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,$d[2006]
215   $a1 electronic resource (13 pages) $ccharts
300   $a"Pharmacology and toxicology."
300   $a"March 2006."
517   $aGuidance for industry 
606   $aDrugs$zUnited States$xTesting
606   $aBiologicals$zUnited States$xTesting
615  0$aDrugs$xTesting.
615  0$aBiologicals$xTesting.
712 02$aCenter for Drug Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910696966603321
996   $aGuidance for industry$93434577
997   $aUNINA